According to a new study published recently by the Johns Hopkins Bloomberg School of Public Health and George Washington University, Xarelto, along with Pradaxa, may pose an increased risk of gastrointestinal bleeding in patients. Patients who instead choose to take warfarin, an older anticoagulant, appear to have a decreased change of experiencing these side effects. The study followed 46,000 patients that were given either Pardaxa, Xarelto or warfarin and watched them for six months. Although this study is preliminary and limited, the results suggest a connection between Xarelto and gastrointestinal issues.
Xarelto has continued to come under fire because of its side effects. It was originally touted as a “one-size-fits all” drug. Doctors and patients also praised the drug because it did not require the same routine monitoring that warfarin does. However, because of this fact, many doctors may not notice that their patients are having issues with the drug until its too late. Additionally, unlike warfarin, Xarelto does not yet have an antidote, which means that it’s essential for doctors to be aware of how their patients are doing. Because of all of these issues and more, lawsuits are being filed by patients who have been harmed by the drug.
Legal Commentary
Xarelto attorneys within our firm are studying, examining and investigating current Xarelto claims on behalf of people and their families who may have been injured by the drug. Some of the side effects include hemorrhaging, internal bleeding, stroke and or death. If you or a loved one has experienced any side effects while taking Xarelto, contact our Xarelto lawyers to discuss the facts of your potential case.
———
About Nachawati Law Group
Nachawati Law Group represents parties in mass tort litigation, businesses and governmental entities in contingent litigation, and individuals in complex personal injury litigation. For more information, visit contact or call 214-890-0711.
